Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1021309Generated: November 4, 2026

Ammonium Chloride → 2-Pyridinecarboxylic acid, 5-[4-[[1-[2-fluoro-3-(hydroxymethyl)phenyl]-3-azetidinyl]oxy]-1-piperidinyl]-, methyl ester

https://huagongshe.com/reaction/1021309

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAmmonium ChlorideHCID 25517—
ReactantPotassium Phosphate, TribasicHCID 62657—
ReactantMethyl 5-bromopyridine-2-carboxylateHCID 7016458—
ReactantTBAF tetrahydrofuranHCID 11078149—
Reactant2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
ReactantHCID 86686249HCID 86686249—
CatalystHCID 178418476HCID 178418476—
SolventChloroformHCID 6212—
SolventTetrahydrofuranHCID 8028—
Solvent1,4-DioxaneHCID 31275—
Product2-Pyridinecarboxylic acid, 5-[4-[[1-[2-fluoro-3-(hydroxymethyl)phenyl]-3-azetidinyl]oxy]-1-piperidinyl]-, methyl esterHCID 6830906735%

Reaction Conditions

Temperature100 °C

Reaction Steps

4-({1-[3-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-2-fluorophenyl]azetidin-3-yl}oxy)piperidine (250 mg) and dioxane (7 ml) were mixed, and methyl 5-bromopyridine-2-carboxylate (170 mg), palladium acetate (II)(15 mg), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (60 mg), and tripotassium phosphate (400 mg) were added thereto, followed by stirring 100° C. for 48 hours. The reaction mixture was cooled to room temperature, and filtered by the addition of CHCl3 and Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc). The purified product thus obtained was mixed with THF (5 ml), and a 1.0 M TBAF/THF solution (0.63 ml) was added thereto, followed by stirring at room temperature for 1 hour. A saturated aqueous ammonium chloride solution and CHCl3 were added to the reaction mixture, and the organic layer was dried over Na2SO4 and then concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (CHCl3/MeOH) to obtain methyl 5-[4-({1-[2-fluoro-3-(hydroxymethyl)phenyl]azetidin-3-yl}oxy)piperidin-1-yl]pyridine-2-carboxylate (92 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08716470B2
Source datasetuspto-grants-2014_05
ORD IDord-2e0270fdcbdc40b0a39f0a941ae0896d
Source noteuspto-grants-2014_05